Intravesical CAR T-Cell Therapy Reduces Bladder Cancer Growth in Preclinical Model

Researchers identified the protein MUC16 as a clinically relevant target for bladder cancer, and engineered MUC16-targeting CAR T cells that, when delivered into the bladder via a catheter, controlled bladder tumors in mice.

The post Intravesical CAR T-Cell Therapy Reduces Bladder Cancer Growth in Preclinical Model appeared first on GEN - Genetic Engineering and Biotechnology News.